Compounds > buserelin
Page last updated: 2024-08-23

buserelin and Pituitary Neoplasms

buserelin has been researched along with Pituitary Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's4 (44.44)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beardwell, CG; Chapman, AJ; Dutton, J; MacFarlane, IA; Shalet, SM; Sutton, ML1
Chin, WW; Conn, PM; Kaiser, UB; Katzenellenbogen, RA1
Awara, WM; Conn, PM; Guo, CH1
Damjanovic, S; Popovic, V1
Damjanović, S; Kendereski, A; Manojlović, D; Micić, D; Mićić, J; Petakov, M; Popović, V; Sumarac, M1
Daniels, M; Dunn, J; Kendall-Taylor, P; Newland, P; White, MC1
de Jong, FH; Lamberts, SW; Reubi, JC; Uitterlinden, P1
Cabranes, JA; Charro, AL; Rubio, MA; Schally, AV1
Claustrat, B; Forest, MG; Lahlou, N; Lejeune, H; Loras, B; Sassolas, G; Trouillas, J1

Other Studies

9 other study(ies) available for buserelin and Pituitary Neoplasms

ArticleYear
Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
    Clinical endocrinology, 1984, Volume: 21, Issue:2

    Topics: Adenoma, Chromophobe; Bromocriptine; Buserelin; Dexamethasone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Middle Aged; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Thyroxine

1984
Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
    Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:8

    Topics: Adenoma; Animals; Buserelin; Calcium; DNA, Complementary; Gene Expression Regulation; Glycoprotein Hormones, alpha Subunit; Gonadotropin-Releasing Hormone; GTP-Binding Proteins; Luciferases; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Pituitary Neoplasms; Prolactin; Protein Kinase C; Rats; Receptors, LHRH; Receptors, Thyrotropin-Releasing Hormone; Recombinant Fusion Proteins; Signal Transduction; Thyrotropin-Releasing Hormone; Transfection; Tumor Cells, Cultured

1994
Effects of Asn318 and Asp87Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation.
    Endocrinology, 1996, Volume: 137, Issue:2

    Topics: Amino Acid Sequence; Animals; Asparagine; Aspartic Acid; Buserelin; Cyclic AMP; Down-Regulation; Inositol Phosphates; Mice; Pituitary Neoplasms; Point Mutation; Prolactin; Rats; Receptors, LHRH; Signal Transduction; Tumor Cells, Cultured; Up-Regulation

1996
The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
    Thyroid : official journal of the American Thyroid Association, 1998, Volume: 8, Issue:10

    Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Buserelin; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Gonadotropins, Pituitary; Humans; Immunohistochemistry; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone

1998
Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
    Journal of endocrinological investigation, 1991, Volume: 14, Issue:4

    Topics: Adenoma, Chromophobe; Adult; Buserelin; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Testosterone

1991
Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    The Journal of endocrinology, 1988, Volume: 118, Issue:3

    Topics: Adenoma; Adult; Aged; Buserelin; Cells, Cultured; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Time Factors

1988
Effects of gonadotropin-releasing hormone and its agonists on prolactin secretion from normal and tumorous pituitary cells.
    Neuroendocrinology, 1989, Volume: 49, Issue:2

    Topics: Animals; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; In Vitro Techniques; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Reference Values

1989
Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:2

    Topics: Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Progesterone; Prolactin; Prolactinoma; Testosterone; Triptorelin Pamoate

1989
Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:1

    Topics: Adenoma; Adult; Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Stimulation, Chemical; Testosterone; Time Factors; Triptorelin Pamoate

1988